The long-term effect of mTOR inhibition on lipid and glucose metabolism in tuberous sclerosis complex: data from the Dutch TSC registry

por Mulder, Femke V. M., Peeters, Evelien F. H. I., Westerink, Jan, Zwartkruis, Fried J. T., de Ranitz-Greven, Wendela L.
Publicado 2022

Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex

por Vergeer, Menno, de Ranitz‐Greven, Wendela L., Neary, Maureen P., Ionescu‐Ittu, Raluca, Emond, Bruno, Sheng Duh, Mei, Jansen, Floor, Zonnenberg, Bernard A.
Publicado 2019

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease

por Smidt, Lisanne C. A., Visseren, Frank L. J., de Ranitz-Greven, Wendela L., Nathoe, Hendrik M., Kappelle, L. Jaap, de Borst, Gert J., de Valk, Harold W., Westerink, Jan
Publicado 2021

Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM

por Müller, Annelieke R., Luijten, Michiel A. J., Haverman, Lotte, de Ranitz-Greven, Wendela L., Janssens, Peter, Rietman, André B., ten Hoopen, Leontine W., de Graaff, Laura C. G., de Wit, Marie-Claire, Jansen, Anna C., Gipson, Tanjala, Capal, Jamie K., de Vries, Petrus J., van Eeghen, Agnies M.
Publicado 2023

Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM

por Müller, Annelieke R., Luijten, Michiel A. J., Haverman, Lotte, de Ranitz-Greven, Wendela L., Janssens, Peter, Rietman, André B., Hoopen, Leontine W.ten, de Graaff, Laura C. G., de Wit, Marie-Claire, Jansen, Anna C., Gipson, Tanjala, Capal, Jamie K., de Vries, Petrus J., van Eeghen, Agnies M.
Publicado 2023